Search
A
ACC Ltd
Score 68/100
• Decent
ACC Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health87/100
Valuation
80/100 · PB 1.7927
Technical
Avoid
1M -3.656%
6M -5.028%
1Y -20.532%
Confidence100%
C
Cholamandalam Financial Holdings Ltd
Score 68/100
• Decent
Cholamandalam Financial Holdings Ltd shows decent potential for growth, but faces challenges in profitability and valuation metrics.
Company’s Health61/100
Valuation
80/100 · PB 1.3495
Technical
Avoid
1M 0.114%
6M -1.219%
1Y 25.948%
Confidence100%
M
Metro Brands Ltd
Score 68/100
• Decent
Metro Brands Ltd shows decent growth potential but faces challenges in valuation and competition.
Company’s Health95/100
Valuation
20/100 · PB 18.265
Technical
Avoid
1M 4.584%
6M -4.374%
1Y -8.719%
Confidence100%
E
Exide Industries Ltd
Score 68/100
• Decent
Exide Industries Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health64/100
Valuation
60/100 · PB 2.2799
Technical
Avoid
1M -0.978%
6M -5.224%
1Y -19.014%
Confidence100%
N
NLC India Ltd
Score 68/100
• Decent
NLC India Ltd shows decent growth potential but faces valuation concerns and execution risks.
Company’s Health75/100
Valuation
80/100 · PB 1.5411
Technical
Avoid
1M -10.165%
6M 3.125%
1Y -6.552%
Confidence100%
S
SJVN Ltd
Score 68/100
• Decent
SJVN Ltd shows potential in the renewable energy sector, but faces challenges in profitability and market sentiment.
Company’s Health61/100
Valuation
60/100 · PB 2.0024
Technical
Avoid
1M -12.842%
6M -27.671%
1Y -38.951%
Confidence100%
C
CRISIL Ltd
Score 68/100
• Decent
CRISIL Ltd is positioned well within its industry with solid growth and profitability metrics, making it a decent investment opportunity.
Company’s Health97/100
Valuation
20/100 · PB 12.8267
Technical
Avoid
1M -7.046%
6M -18.607%
1Y -18.602%
Confidence100%
A
Astral Ltd
Score 68/100
• Decent
Astral Ltd shows a decent investment opportunity with solid growth and profitability metrics, though some risks and valuation concerns exist.
Company’s Health87/100
Valuation
20/100 · PB 10.3045
Technical
Avoid
1M -10.086%
6M -5.523%
1Y -22.745%
Confidence100%
G
Gujarat Fluorochemicals Ltd
Score 68/100
• Decent
Gujarat Fluorochemicals Ltd shows decent potential with consistent growth and profitability metrics, but some risks in governance and valuation should be monitored.
Company’s Health74/100
Valuation
20/100 · PB 5.2168
Technical
Avoid
1M -2.492%
6M -5.846%
1Y -20.818%
Confidence100%
P
Petronet LNG Ltd
Score 68/100
• Decent
Petronet LNG Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health79/100
Valuation
60/100 · PB 2.0296
Technical
Avoid
1M -3.282%
6M -11.413%
1Y -21.589%
Confidence100%
C
Container Corporation of India Ltd
Score 68/100
• Decent
Container Corporation of India Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
Company’s Health76/100
Valuation
40/100 · PB 3.0773
Technical
Avoid
1M -4.421%
6M -18.214%
1Y -23.372%
Confidence100%
D
Dalmia Bharat Ltd
Score 68/100
• Decent
Dalmia Bharat Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health66/100
Valuation
60/100 · PB 2.221
Technical
Avoid
1M -2.574%
6M -1.511%
1Y 7.077%
Confidence100%
C
Cochin Shipyard Ltd
Score 68/100
• Decent
Cochin Shipyard Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
Company’s Health87/100
Valuation
20/100 · PB 7.5403
Technical
Avoid
1M -9.349%
6M -24.858%
1Y -2.932%
Confidence100%
B
Balkrishna Industries Ltd
Score 68/100
• Decent
Balkrishna Industries Ltd shows a decent investment potential with strong fundamentals, but caution is advised due to valuation concerns and execution risks.
Company’s Health95/100
Valuation
40/100 · PB 4.3716
Technical
Avoid
1M -1.643%
6M -4.86%
1Y -16.508%
Confidence100%
G
GlaxoSmithKline Pharmaceuticals Ltd
Score 68/100
• Decent
GlaxoSmithKline Pharmaceuticals Ltd shows decent fundamentals but faces challenges in profitability and market sentiment. It is a stable player in a growing sector, but caution is advised due to valuation concerns and execution risks.
Company’s Health84/100
Valuation
20/100 · PB 22.5793
Technical
Avoid
1M 5.487%
6M -21.663%
1Y 12.877%
Confidence100%